Labshake search
Citations for Haematologic Technologies :
1 - 20 of 20 citations for Recombinant Human Von Willebrand Factor His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2022Quote: ... Human coagulation Factor X (hFX) (Haematologic Technologies) was added to diluted vectors at a final concentration of 8 μg/mL ...
-
bioRxiv - Biochemistry 2019Quote: ... factor V (Haematologic Technologies Inc., Essex Junction, VT), recombinant factor IX (Benefix® ...
-
bioRxiv - Bioengineering 2020Quote: ... and Factor Xa were purchased from Haematologic Technologies, Inc ...
-
bioRxiv - Bioengineering 2020Quote: Positive controls of Innovin (Siemens Healthcare Diagnostics, Germany) or Factor IXa (Haematologic Technologies, VT, USA) were used separately ...
-
bioRxiv - Biochemistry 2021Quote: Plasma coagulation factors and 25:75 PS:PC (phosphatidylserine-phosphatidylcholine) phospholipids were purchased from Haematologic Technologies Incorporated (Vermont ...
-
bioRxiv - Microbiology 2021Quote: ... Factor X and prothrombin-deficient plasma were obtained from Haematologic Technologies (#FX-ID and #FII-ID). Russell’s Viper Venom test was performed with 10 µg/ml snake venom from Vipera russelli (RVV ...
-
bioRxiv - Cell Biology 2023Quote: ... Human α-thrombin (HCT-0020, Haematologic technologies) diluted in PBS was used at a final concentration of 2 U/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... Human α-thrombin (10 nM; Haematologic Technologies) or tumor necrosis factor alpha (TNFα ...
-
bioRxiv - Bioengineering 2023Quote: ... Human α-thrombin (HCT0020) was purchased from Haematologic Technologies, Inc ...
-
bioRxiv - Pathology 2023Quote: Human FXIa (Haematologic Technologies Inc. Essex Junction, VT, USA) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl (FUJIFILM Wako Pure Chemical Corp. ...
-
bioRxiv - Bioengineering 2022Quote: ... or 13.5 nM human α-thrombin (Haematologic Technologies, HCT-0020) in TCNB buffer ...
-
bioRxiv - Biophysics 2019Quote: The enzymatic activity of human α-thrombin (Haematologic Technologies, Essex, USA) was assessed by following its amidolytic activity toward the chromogenic substrate Tos-Gly-Pro-Arg-p-nitroanilide (Chromozym TH ...
-
bioRxiv - Biochemistry 2021Quote: ... EGRck-active site blocked human fIXa was purchased from Haematologic Technologies. The plasmid encoding for membrane scaffold protein MSP1D1 was purchased from AddGene.43
-
bioRxiv - Microbiology 2022Quote: ... Purified human alpha-thrombin was purchased from Haematologic Technologies (Cat# 50-883-435).
-
bioRxiv - Biochemistry 2022Quote: Heterologously expressed murine ovastacin was purified and activated with human plasmin (Haematologic Technologies) as described (Karmilin et al. ...
-
bioRxiv - Cell Biology 2021Quote: ... BOECs were stimulated with 1 U/ml human α-thrombin (HCT-0020, Haematologic technologies) diluted in phosphate-buffered saline.
-
bioRxiv - Neuroscience 2023Quote: ... 1 μl of purified human alpha-thrombin (1UI; HCT-0020, Haematologic Technologies Inc., USA) was injected into the MCA with a glass pipette ...
-
bioRxiv - Synthetic Biology 2022Quote: ... was used as a chromogenic substrate to test the amidolytic activity of human α-thrombin (Haematologic Technologies). Purified chi and mad inhibitors were buffer-exchanged to the assay buffer (pH 8 ...
-
bioRxiv - Neuroscience 2021Quote: ... the eye cup was treated for ∼15 minutes with human plasmin (∼50 μg/mL, Sigma or Haematologic Technologies) to aid vitreous removal ...
-
bioRxiv - Neuroscience 2019Quote: ... the eye cup was treated for ∼ 15 minutes with human plasmin (∼ 50 µg mL−1, Sigma or Haematologic Technologies) to aid vitreous removal.